Strategy
- - - Strategy
      
      Helping leadership teams break through to next-level growth with strategic marketing consultation services.
      
      Talk with us
  - - Branding
    - Build your brand
  - - Strategic Consulting
    - Achieve next-level growth
  - - Integrated Marketing
    - Make every asset count
Lead Generation
- - - Lead Generation
      
      Connecting prospects with your brand, building pipeline, and driving growth.
      
      Start Now
  - - Digital Marketing
    - Reach your audience
  - - Advertising
    - Maximize your ad buy
  - - Events
    - End-to-end event support
Marketing Operations
- - - Marketing Operations
      
      Streamlining operations in B2B marketing to achieve measurable outcomes.
      
      Learn More
  - - Content Creation
    - We speak science
    - User Experience
    - Form and function
  - - Public Relations
    - Amplify awareness
    - Websites
    - Websites that resonate
  - - Social Media
    - Drive more engagement
Marketing Analytics
Why BWS
- - - Why BWS
      
      Take your brand out of the lab and into the light.
      
      Read More
  - - About Us
    - Knowledge and experience
    - Our Approach
    - Integrated engagement
  - - Our Team
    - The expertise you need
    - News & Events
    - What we’re up to
  - - Podcast
    - Expert perspectives
    - Blog
    - Marketing insights
Portfolio
Contact Us

Thought Leadership Development

Our Clients Make the News

2026

ESG & Strategic Partnerships in Pharma Supply Chain

From Shore to Shore

Industry Insights: Advancing oligonucleotide therapeutics through regulatory approvals, clinical data, and AI-enabled discovery

Is Pharma Bigger in Texas?

Roundup: Removing Impurities from Biomanufacturing

Hovione Planning Ribbon-Cutting at NJ Facility – A Behind-the-Scenes Preview

The Data Blind Spot Stalling Cosmetics R&D

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing’s First Half of 2026

How agentic AI is reshaping laboratory workflows

Creating Amorphous Solid Dispersions Via Spray Drying (pg. 20-22)

The AI Platform Transforming Product Development—From Lab to Launch

Investors in Science Need Partners That Can Scale Alongside Innovation

SPECIAL FEATURE – Outsourcing Formulation Development & Manufacturing: Connecting Your Project to the Right Service Provider

Cleanroom Technology May 2026

Driving the Data-Rich Future of OSDs

Inside Agilent’s Colorado Oligo Build-Out: Four Trains, 100% Solvent Reclaim, and a 2027 Capacity Double | Interview with Blake Unterreiner

How is the increasing complexity of modalities reshaping CDMO differentiation and specialization strategies?

Agentic AI in the Laboratory Moves Beyond Prompt-Based Tools

Continuous Tableting Comes of Age: Innovations Driving Supply Chain Flexibility and Speed to Market (Pg. 31-33)

Agilent’s Expanding Role in Advanced Therapeutics | Contract Pharma

Bioavailability & Solubility: Experimental Techniques Combined With Computational Decision-Making Rapidly ID the Most Viable Enhancement Pathway

Before the Algorithm: Why Data Infrastructure Is the Competitive Advantage in Product Development

Hovione expansions aim to meet industry’s dual sourcing appetite

LGM Pharma Talks Texas, Colorado Investments at DCAT Week

Pittcon 2026 guide to exhibitors, launches and key trends

Pittcon 2026 recap: 7 trends that defined the show

The Trends Set to Reshape Labs as Seen at Pittcon 2026

What’s Next for Laboratory Science in 2026

LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities

OSD Manufacturing Enters a New Era: Key Trends Shaping the Global Market | Contract Pharma

Insights on New Modalities, Digital Integration, and Manufacturing Innovation

CEO Spotlight: Hovione’s Jean-Luc Herbeaux

LABTips: GxP and Data Integrity

Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience

Pharmaceutical Supply Chain Resilience in a Shifting Market

CEO Spotlight: Hovione’s Jean-Luc Herbeaux

Navigating Geopolitical Shifts, M&A, and Supply Chain Resilience

Advancing Pharmaceutical Quality through Integrated Digital Systems and Collaborative Scientific Innovation

The Critical Need for Digital Transformation in the Peptide and API Sectors

Navigating Financial and Opportunity Risks in Accelerated Drug Launches

2025

Mitigating Disruptions in API Supply: Building Resilient and Redundant Sourcing Strategies

Enhancing Bioanalysis and Drug Development with Advanced Tools and Technologies

Strategies for Successful Scale-Up of Suppository Drug Products

Drug Digest: Small Molecules, APIs, and Excipients—Trends, Challenges, and Opportunities

Keys to Navigating the Complex Drug Supply Chain

What Every Lab Needs to Know Before Choosing a LIMS

Rapid drop-of-blood test distinguishes bacterial from viral infections

Emerging Tools, Integrated Controls Impact Tech Transfer

New Sepsis Testing Tools Emerging While Adoption Drags Amid Clinical Utility Concerns

How SaaS 2.0 Is Transforming Lab Informatics

5 Key Trends Shaping the Future of LIMS

CGT Outsourcing: Trends, Challenges, and Future Growth

From Pathogen to Infectious Disease Diagnosis: Test Determines Between Bacterial and Viral Infections in 15 Minutes

Novel Oncology Biotherapeutics: Gene Therapies

Analytical Testing Outsourcing: Growth Trends & Outlook

DCAT Week 2025: Expanding Sterile Injectables Capacity

DCAT Week 2025: Challenges of Expanding Market Demand

Why LabVantage Wants Researchers to Have Conversations With Their Data

2025 Emerging Trends as Seen at Pittcon

Panel Discussion on AI and ESG: Shaping the Future of Sustainable Global Supply Chains

OSD Manufacturing Market: Growth Trends & Outlook

Modernizing Laboratory Workflows: LabVantage on the Future of LIMS

Steps to Process Development Optimization

Is AI truly transforming drug development, or are we still navigating through the hype?

What strategies are ensuring supply chain resilience in a post-COVID world?

Sustainability in Pharmaceutical Outsourcing

How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?

2024

AI Can’t Fix Bad Data: Why Semantic Technologies Are Key to R&D Acceleration

Optimizing Process Development for Microbial Fermentation

Getting Drugs to Patients Faster

Enhancing Quality Through Training

The business case for AI in R&D – Accelerating innovation

How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?

Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?

Tech Transfer in the New World of New Modalities

Securing Sustainability Throughout the Pharmaceutical Supply Chain

Contractors Support Material Testing

Know Thy Enemy: MeMed’s Diagnostic Reduces Antibiotic Overuse in U.S. Trial

Determining If the Patient’s Infection is Bacterial or Viral

Navigating a Material Supplier Change

Dynamic access control: How unidirectional flow can streamline aseptic fill/finish

Expert Statement: Prasad Raje, LGM Pharma

The Evolution of the CDMO Industry

Expert Statement: Davuluri Saharsh Rao, Neuland Labs

Leveraging an Enterprise Laboratory Informatics Platform to Maximize Scientific Data Advantage

CEO Spotlight: Prasad Raje

It’s All About the Small Things

Contracting Out Frees Sponsors Up

Dissecting Dissolution Testing

Considerations in Pharmaceutical Facility Design (CPHI North America 2024)

Flexibility in Outsourcing Models (BIO 2024)

Diversifying the Supply of Raw Materials

Single-use Fermenters for Microbial BioPharma Development & Manufacturing – Page 44

Parenteral Perspectives

SPECIAL FEATURE – Prefilled Syringes & Parenteral Delivery: Next-Gen Injections Feature Technology & Reconstitution

A Platform Approach to Scientific Data Flow Management: Everything You Need to Know

DCAT Week 2024 Prasad Raje CEO at LGM Pharma

At DCAT, firms sought to capitalize on WuXi woes

Selkirk Pharma Sterile Manufacturing Facility, Spokane, Washington, USA

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Newsmakers Q&A: BioVectra

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

What strategies are being employed to accelerate product development and commercialization without compromising quality?

NEXT-GEN PHARMA: Navigating The AI Revolution In Drug Development and Distribution

Bio/Pharma Outsourcing Innovation eBook February 2024

High-Growth Microbial Fermentation for the Manufacture of Biologics

Proving It’s Clean with Analytics

An interview with BioVectra executives at CPHI Barcelona

2023

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

What Do You See As The Most Significant Regulatory Decision Or Guidance On The Horizon For 2024 (Or Beyond)?

Training for Operational Excellence

Establishing a Framework for Reliable Pharma Labeling

Reducing Time Not Quality for Biologics Approvals

Lab of the Future: Optimised Lab Informatics Transform Scientific Data into Strategic Assets

2023: The Year of the Upturn?

Changing the Paradigm in AI Implementation

Trends in Formulation for Highly Potent Drugs

Optimizing Fermentation Processes for Biologics Manufacturing

Hi-Fidelity Fill/Finish for Biologics

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Data Integrity’s Impact in Drug Substance Testing

Inside the Lab of the Future: How Advanced Technologies and Optimized Lab Informatics Can Turn Scientific Data into a Valuable Business Asset

Interview with Jubilant’s President Chris Preti

Interview with LGM Pharma’s CEO, Prasad Raje

LSKH DCAT 2023 Bormioli Pharma

LSKH DCAT 2023 LGM Pharma

Harnessing Technology to Ensure Drug Safety

BioVectra’s Biologic Expansion

Communication is Key in Complex Tech Transfer

PharmTech Bio/Pharma Outsourcing Innovation E-Book

What do you view as the most disruptive or transformational technology or development on the horizon?

In what international markets do you anticipate significant developments in the near future?

Five Insights to Maximize Customer-Centric Acquisition Growth

Combatting Future Viral Threats with Vaccine Advances

Drug Solutions Podcast: The Future of Vaccine Development

The Flexible Approach to Modern Large & Small Molecule Manufacturing

2022

Video Roundtable: Cell & Gene in a World in Turmoil

eBook: What’s Hot in Outsourcing & Supply Chains?

The Medicine Maker – A Special Series: Supply Chain & Outsourcing

Fall pharma happenings | Pharma Manufacturing

Shining a Light on Junior Pharmaceuticals

Trends Toward Outsourcing Buffer Manufacturing

After M&A sprint, newly unveiled Actylis aims to be ‘much more than just a distributor’: CEO

What is your plan to build a more sustainable business practice in the coming years?

What key indicators do you look at to predict the future of this industry?

Meeting the need for innovative small molecule APIs

Cell and Gene Champions 4

What Goes Wrong When API Quality is Compromised?

BioVectra chief commercial officer has played a pivotal role in firm’s success

Why BioVectra has big mRNA biomanufacturing ambitions

5 MINUTES WITH: Mikael Hagstroem, CEO, LabVantage Solutions

Drug Solutions Podcast: The Evolving Landscape of Oral Solid Dosage Forms

CDMO Roundtable: Managing Orphan Drug Projects

BioVectra: From small molecules to large player

Expansion accelerates across pharma

Digital Lab Transformation in the Energy and Petroleum Sectors

Meeting Demand for Semi-Solid Doses

Supply Chain Considerations for Ensuring Quality

Formulated fill-finish:From curiosity to cure

Drug Digest Video: Pairing the Right APIs and Excipients for Optimizing Formulations

CDMOs – Thinking Through Complexity, James Grabowski, PhD, VP, Portfolio and Sourcing, Curia

CDMOs & Pharma: How are Supply Practices Changing?

2021

Assurance of supply takes precedence

Lipids for Self-Emulsifying Drug Delivery Systems

Giving drug researchers control of their data

Increased Data Flow Demands Strategic Management

Global Regulatory Approach to API Manufacturing

API Development and Manufacturing: Advantages of Working with Small Molecules

Determining Shelf Life: Reading the Stability Testing Data

Partnering with a CDMO for Orphan Drug Development

Spray Drying: A Proven Approach to Enhance the Solubility of APIs

Outsourcing the Manufacture of Clinical Trial APIs

CMOs and CDMOs Adjust to Pandemic Response and Beyond

CDMO AMRI rebrands and snags a pair of smaller companies to aid its shift to become a global brand name

Curia CEO seized ‘huge open door’ to biologics with back-to-back buyouts of LakePharma, Integrity Bio

Balancing Pressing Priorities

As Curia expands, it will add API site in upstate New York; In battle against food allergies, Alladapt to build site to prep for PhIII trials

Biocatalysis: An Indispensable Tool for API Synthesis

Packaging Considerations for Clinical Trial Materials

What Does the Fourth Industrial Revolution Mean for Research?

Inclusion is everything: expanding diversity in clinical trials

Pharma ramps up innovation in response to COVID-19

Building supply chain resiliency to ensure access to medicines

The cost of bringing US pharma manufacturing home

Collaboration Is Key to Combatting Cybercrime

Business Intelligence For (and From) the Lab

2020

Complying with Lab Data Integrity Practices During COVID-19

Manufacturing Materials for Clinical Trials

Fermentation Finds Fans in Small-Molecule API Synthesis

Using a Development and Submission Stage Gate System to Help Improve Drug Product Development Outcomes

Ensuring a Safe and Robust Supply of Pharma Materials

CEO uses scientific data to drive better outcomes in the lab of the future

Supply Chain Logistics Have Changed Are You Keeping Up?

Supply chain security in an insecure world: Why drug developers are partnering with a new breed of api sourcing experts

The Applications of Laboratory Information Management Systems

Procalcitonin serial testing to inform treatment of sepsis

2019

Lab Informatics at the Centre of Digital Transformation Strategies

API Supply Chain Strategy

Best practices in onboarding open channel reagents and suppliers

LIMS Meets the Modern Laboratory

A Brave New World of Data Integrity

LabVantage: Transforming the Landscape of Lab Informatics

Patient-Centric Drug Development Comes of Age

2018

Outsourcing Development: Small-Scale to Commercial

Outsourcing Formulation Development & Manufacturing: CDMOs Are Innovating for 21st-Century Medicine

The Biorepository Solution Giving Cancer Researchers Access to Over 150,000 Tumor Samples

LabVantage Launches Cannabis-Specific LIMS!

Procalcitonin Measurement for Effective Antibiotic Stewardship

Halo Pharma’s Capabilities Mentioned

Trends in Primary Packaging Materials for Parenterals

Developing Fixed-Dose Combinations

FDCs on the Rise

LabVantage: Purpose-built LIMS packages save time and money

The drug industry’s data integrity problem

2017

Biobanking Can Dispense with Data Silos

Advantages of Fixed-Dose Combo Drug Products

Navigating the Shifting Landscape of Contract API Manufacturing

“Brandwidth Solutions really helped put Halo Pharma on the map with the types of customers we wanted to attract. The team was a pleasure to work with, staying focused on our goals and bringing engaging ideas and concepts to the table — then delivering on the execution, from content to web design. Their marketing expertise helped us to position our expertise in a competitive market — and stand out.”

– L. Lee Karras
Chief Executive Officer, Halo Pharmaceutical

< PREVIOUS

NEXT >